Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Breast Carcinoma: early-phase trial registry
63 of 107 indexed Breast Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #120 of 28,707 conditions by registered trial count.
107 US clinical trials · 63 currently recruiting · #120 of 28,707 conditions by registered trial count
Breast Carcinoma: 107 US clinical trials tracked, 63 recruiting.
Breast Carcinoma is the subject of 107 registered US clinical trials on ClinicalTrials.gov, 63 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 21 of these trials.
Enrollment posture brief
Registry condition breast-carcinoma
OPEN 63 | RECR 59% | LATE 5 | EARLY 33 | RANK #120 | SPON 21
Volume-matched condition peers
Nearest open-share peer: Alcohol Use Disorder (59% recruiting · 185 trials)
Breast Carcinoma lists 63 open slots (59% of 107 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Breast Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Breast Carcinoma is recruiting above its size-band peers.
63 of 107 indexed trials (58.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Breast Carcinoma research.
Mayo Clinic accounts for 21 of 107 trials (19.6%). 30 distinct sponsors appear on at least one study for this condition label.
-
Typical Breast Carcinoma enrolment sits around 126 participants.
Median target enrolment is 126 among the 107 trials that report a genuine target (sentinel values excluded). 45 of those (42.1%) plan for fewer than 100 participants.
-
Breast Carcinoma research is mostly interventional.
77 interventional and 30 observational studies make up this index (72% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
107 total, page 2 of 3
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
Mayo Clinic
NCT05755269
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
Mayo Clinic
NCT06055881
A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation
University of Washington
NCT06772181
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
Mayo Clinic
NCT06274034
Surviving Daily Life
Thomas Jefferson University
NCT07054723
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
NCT07118176
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
Memorial Sloan Kettering Cancer Center
NCT06557148
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mayo Clinic
NCT07285044
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
City of Hope Medical Center
NCT04913064
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
City of Hope Medical Center
NCT06130826
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
Mayo Clinic
NCT06953245
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
University of Michigan Rogel Cancer Center
NCT06915168
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
M.D. Anderson Cancer Center
NCT05406232
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
NCT02465060
Breast Cancer WEight Loss Study (BWEL Study)
Alliance for Clinical Trials in Oncology
NCT02750826
Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer
Ohio State University Comprehensive Cancer Center
NCT05325151
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy
Immutep S.A.S.
NCT05747794
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
NCT04905082
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
M.D. Anderson Cancer Center
NCT02194387
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
Alliance for Clinical Trials in Oncology
NCT04711109
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Fred Hutchinson Cancer Center
NCT04081779
Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy
Alliance for Clinical Trials in Oncology
NCT04989504
Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study
Mayo Clinic
NCT05703399
Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study
M.D. Anderson Cancer Center
NCT06584396
Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma
Washington University School of Medicine
NCT04849871
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio
NCT07038369
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
University of California, Irvine
NCT02436993
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
NCT01366144
Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma
Washington University School of Medicine
NCT03612648
Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications
M.D. Anderson Cancer Center
NCT05046301
Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women
M.D. Anderson Cancer Center
NCT04267796
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
M.D. Anderson Cancer Center
NCT02876107
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer
M.D. Anderson Cancer Center
NCT05226663
Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction
M.D. Anderson Cancer Center
NCT05130580
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
Providence Health & Services
NCT03650894
An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction
M.D. Anderson Cancer Center
NCT03990610
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer
M.D. Anderson Cancer Center
NCT05132296
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
NCT04147494
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
Julie L. Sutcliffe, Ph.D
NCT03164486
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
Washington University School of Medicine
NCT02204098
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
Irada Ibrahim-zada
NCT05150652
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Gynecologic Oncology Group
NCT01139957
Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer
University of Rochester NCORP Research Base
NCT03367572
CARE: Cancer Risk Perception and Women of Color
Mayo Clinic
NCT06036875
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Mayo Clinic
NCT04456140
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
NCT03180294
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Xencor
NCT03517488
A Correlational Study: Breast Cancer-related Chest Wall Lymphedema, Quality of Life, and Shoulder Function
Mayo Clinic
NCT06285747
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
Jonsson Comprehensive Cancer Center
NCT06090630
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Ohio State University Comprehensive Cancer Center
NCT03307044
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 18 |
| Phase 3 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Breast Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Breast Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Breast Carcinoma page
107 registered trials, 63 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 63 Breast Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mayo Clinic sponsors the most Breast Carcinoma trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Breast Carcinoma condition card totals 107 registered trials; most-linked intervention Questionnaire Administration; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.